Maura L. Gillison Dies at 61, Leaving Behind Research That Changed the Understanding of HPV and Oropharyngeal Cancer

 Professor Maura L. Gillison, a pioneering medical oncologist and molecular epidemiologist, died on June 21, 2026, at the age of 61, leaving behind a scientific legacy that reshaped the understanding of HPV-related cancers. Her research challenged long-standing assumptions about cancers of the throat and helped establish that many oropharyngeal cancers linked to human papillomavirus were biologically different from those traditionally associated with tobacco and alcohol. For patients, physicians, researchers, and public health professionals, her work changed how an increasingly important group of cancers was understood.

Born January 4, 1965, in London, Ontario, Gillison spent much of her childhood in the Cleveland area after her family moved frequently. Her academic path reflected an early commitment to medicine and scientific investigation. She graduated summa cum laude from Duke University in 1987 before earning her medical degree from Johns Hopkins in 1991. She later pursued doctoral training in clinical investigation, developing the research foundation that would eventually lead to some of her most influential discoveries in cancer epidemiology.

Gillison's research helped establish a critical connection between HPV, particularly HPV-16, and oropharyngeal cancer. Work originating from her doctoral research, followed by influential findings published in The New England Journal of Medicine, helped demonstrate that HPV-positive throat cancers were not simply another form of the cancers traditionally connected with smoking and alcohol. Instead, they represented a distinct disease with different biological characteristics. That insight changed the direction of research and influenced how physicians approached patients with these cancers.

The significance of her discoveries extended beyond the laboratory. As evidence accumulated, Gillison's work contributed to changing discussions surrounding cancer staging, treatment strategies, prognosis, and prevention. Her research helped physicians recognize the importance of determining whether a patient's cancer was associated with HPV, an understanding that became increasingly relevant as HPV-related oropharyngeal cancers gained attention. Her contributions therefore connected molecular science with practical questions facing doctors and patients in clinical settings.

Gillison also became a prominent voice in discussions surrounding HPV vaccination. She strongly supported vaccination for both boys and girls, emphasizing that preventing HPV infection could ultimately prevent cancers later in life. Her advocacy reflected a broader understanding of cancer prevention: scientific discoveries are most powerful when they can be translated into actions that protect future generations. By connecting HPV research with public health education, Gillison helped expand the conversation from treating existing disease to preventing cancers before they develop.

Her professional career included academic and research positions at Johns Hopkins, Ohio State University, and MD Anderson Cancer Center. Across those institutions, she contributed to a field that increasingly recognized the complex relationship between infectious disease, molecular biology, epidemiology, and cancer. Her work influenced researchers and clinicians while helping create a stronger scientific foundation for understanding HPV-associated disease. The reach of that influence can be seen in the continued importance of HPV research and vaccination in cancer prevention.

Gillison died at her childhood family home in Willoughby, Ohio, from a rare cancer of the small intestine, according to her husband, Dr. David E. Symer. Her death represents a significant loss to the medical and scientific communities, but her influence will extend well beyond the years of her career. Her research helped patients receive better-informed care, gave physicians a deeper understanding of disease, and strengthened prevention efforts that may protect future generations. Maura L. Gillison will be remembered not only for the questions she asked, but for how profoundly her answers changed medicine.